17 results
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... own benefits and risks ... the hypoglycemia risk ... #pharmacology #pharmacotherapy
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... Jardiance) - Best risk ... • Euglycemic diabetic ... SGLT2 #Inhibitors #Pharmacology ... #Summary #DM2 #diabetes
Metformin - First Line Treatment for Diabetes Type 2
• Start with initial dose of 500 mg
Treatment for Diabetes ... form to minimize risk ... Indications #Titration #Pharmacology ... #Diabetes #DM2
Metformin 
Current Renal Dose Adjustments due to Risk of Lactic Acidosis 
> 60 No adjustment 
45-60
Adjustments due to Risk ... #Dosing #Dose #Pharmacology ... #Diabetes
Debridement and Management of Prosthetic Joint Infection (PJI)
Duration of symptoms <3 weeks OR  <30 days
Joint Infection (PJI ... whether benefit > risk ... Cortes_Penfield #PJI
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Preoperative Risk ... any modifiable risk ... Diabetes regimen ... Recent PCI/stenting ... since elective PCI
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... outcomes in high risk ... effect) • May ↑ risk ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #diabetes
Side Effects of Atypical and Typical Antipsychotics - Comparison Table
Atypical antipsychotics: Risperidone, Quetiapine, Olanzapine, Amisulpride, Ziprasidone
development of diabetes ... syndrome, increased risk ... people), elevated risk ... Table #Psychiatry #Pharmacology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... associated with t risk ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 #diabetes
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... carrying only a low risk ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes